Global Implantable Remote Patient Monitoring Devices Market 2022-2028

September 2022 | 72 pages | ID: GBA0C487D65DEN
Gen Consulting Company

Abstracts

According to Gen Consulting Company, the global implantable remote patient monitoring devices market is set to achieve an incremental growth of USD 8 billion, acelerating at a CAGR of almost 16.8% during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global implantable remote patient monitoring devices market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the implantable remote patient monitoring devices industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, indication, end user, and region. The global market for implantable remote patient monitoring devices can be segmented by product: brain monitoring devices, cardiovascular monitoring devices, gastrointestinal monitoring system, hematological monitoring devices, musculoskeletal monitoring devices, respiratory monitors, others. The cardiovascular monitoring devices segment was the largest contributor to the global implantable remote patient monitoring devices market in 2021. Implantable remote patient monitoring devices market is further segmented by indication: brain disorders, cardiovascular diseases (CVDs), chronic respiratory diseases, diabetes, gastrointestinal diseases, musculoskeletal disorders (MSD), others. According to the research, the CVDs segment had the largest share in the global implantable remote patient monitoring devices market. Based on end user, the implantable remote patient monitoring devices market is segmented into: homecare, hospitals and clinics, others. The hospitals and clinics segment held the largest revenue share in 2021. On the basis of region, the implantable remote patient monitoring devices market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). Globally, North America made up the largest share of the implantable remote patient monitoring devices market.

By product:

• brain monitoring devices
• cardiovascular monitoring devices
• gastrointestinal monitoring system
• hematological monitoring devices
• musculoskeletal monitoring devices
• respiratory monitors
• others

By indication:

• brain disorders
• cardiovascular diseases (CVDs)
• chronic respiratory diseases
• diabetes
• gastrointestinal diseases
• musculoskeletal disorders (MSD)
• others

By end user:

• homecare
• hospitals and clinics
• others

By region:

• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides analysis of the key companies of the industry and their detailed company profiles including Abbott Laboratories, Inc. , BIOTRONIK SE & Co. KG., Boston Scientific Corporation, Dexcom Inc., Lepu Medical Technology ( Beijing ) Co., Ltd., MEDICO S.R.L., Medtronic plc, MicroPort Scientific Corporation, PrepMD RMS, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global implantable remote patient monitoring devices market.
• To classify and forecast the global implantable remote patient monitoring devices market based on product, indication, end user, region.
• To identify drivers and challenges for the global implantable remote patient monitoring devices market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global implantable remote patient monitoring devices market.
• To identify and analyze the profile of leading players operating in the global implantable remote patient monitoring devices market.

Why Choose This Report

• Gain a reliable outlook of the global implantable remote patient monitoring devices market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Brain monitoring devices
Cardiovascular monitoring devices
Gastrointestinal monitoring system
Hematological monitoring devices
Musculoskeletal monitoring devices
Respiratory monitors
Others

PART 6. MARKET BREAKDOWN BY INDICATION

Brain disorders
Cardiovascular diseases (CVDs)
Chronic respiratory diseases
Diabetes
Gastrointestinal diseases
Musculoskeletal disorders (MSD)
Others

PART 7. MARKET BREAKDOWN BY END USER

Homecare
Hospitals and clinics
Others

PART 8. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 9. KEY COMPANIES

Abbott Laboratories, Inc.
BIOTRONIK SE & Co. KG.
Boston Scientific Corporation
Dexcom Inc.
Lepu Medical Technology ( Beijing ) Co., Ltd.
MEDICO S.R.L.
Medtronic plc
MicroPort Scientific Corporation
PrepMD RMS
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER